
    
      We will randomize in a double blind manner 60 consecutive consenting patients being evaluated
      at the three Mayo Clinic Medical Centers with EE to montelukast 20mg daily or placebo daily
      for six months? time. Patients will be in remission after treatment with topical fluticasone
      therapy before enrollment. Patients will fill out a validated dysphagia and side effect
      questionnaire before, during, and at the end of therapy.
    
  